|
Match
|
Document |
Document Title |
|
|
US20120022015 |
METHOD OF TREATMENT AND SUPPLEMENT
A method of treatment and associated nutritional combination is disclosed. The method of treatment includes providing a patient with a nutritional combination including appropriate amounts of... |
|
|
US20110293740 |
TREATMENT SYSTEM AND METHOD FOR OSTEOPENIA AND OSTEOPOROSIS USING NON-SYNTHETIC BIO-AVAILABLE COMPOUNDS
A treatment system and method for osteopenia and osteoporosis using non-synthetic bio-available hormones, vitamins, minerals, and agents may be customized by varying the dosage and formulation of... |
|
|
US20150119321 |
System and Method of Losing Weight
A unique combination of weight loss modalities that produce 20-40 pounds of weigh loss in a six week treatment period. Treatment includes a meal plan chosen to provide adequate protein and... |
|
|
US20110318338 |
TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of... |
|
|
US20110098238 |
ELUCIDATING LIGAND-BINDING INFORMATION BASED ON PROTEIN TEMPLATES
A method, computer-readable medium, and system for identifying compounds from chemical libraries that can be used for the therapeutic treatment of a disease or used as lead compounds in a drug... |
|
|
US20120040014 |
LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
Nutritional supplement formulations suitable for specific enhancement of cell and mitochondrial function comprise enriched formulations of phospholipids and chemical precursors containing... |
|
|
US20120277180 |
Cofactors and Methods for Use for Individuals
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of... |
|
|
US20120114663 |
METHODS TO TREAT ALLERGIC CONDITIONS
Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are... |
|
|
US20110092454 |
Methods For Treating Mycoplasma Related Conditions In Livestock
The present invention provides methods and related kits for treating or preventing a mycoplasma-related bovine disease. In one aspect, for example, a method for treating or preventing a... |
|
|
US20120231089 |
REVERSING AUTONOMIC NERVOUS SYSTEM DYSFUNCTION BY POTENTIATING METHYLATION
A method for reversing stress-induced dysfunctions of a human autonomic nervous system in accordance with Methylation Priority Principle includes repeatedly administering a methylation-promoting... |
|
|
US20130156855 |
ACNE TREATMENT
One example embodiment includes a chemical composition for the treatment of acne. The chemical composition includes pantothenic acid and L-Carnitine. |
|
|
US20150024070 |
INGESTIBLE CANKER SORE TREATMENT
A treatment and prevention formulation for canker sores of the oral cavity including an aqueous alkaline solution having at least three B vitamins, zinc and iron mixed therein and administered to... |
|
|
US20130040910 |
METHOD OF TREATING VITAMIN B12 DEFICIENCY
A novel method and composition for treating vitamin B12 deficiency mammals that fail to respond to oral vitamin B12 therapy. |
|
|
US20110293589 |
METHOD OF TREATING VITAMIN B12 DEFICIENCY
A novel method and composition for treating vitamin B12 deficiency mammals that fail to respond to oral vitamin B12 therapy. |
|
|
US20150038452 |
Methods of Treating Optic Disorders
The present invention relates to methods for treating optic disorders or for reducing or alleviating the signs, symptoms, or pathological conditions related to such optic disorders. In particular,... |
|
|
US20110319356 |
Methods Of Treating Optic Disorders
The present invention relates to methods for treating optic disorders or for reducing or alleviating the signs, symptoms, or pathological conditions related to such optic disorders. In particular,... |
|
|
US20110071102 |
Compositions and Methods to Treat Recurrent Medical Conditions
The invention describes methods and compositions for alleviating recurrent medical afflictions for which anxiety may cause or exacerbate the affliction. A subject suffering from the affliction is... |
|
|
US20150132410 |
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALCOHOL-INDUCED HANGOVER SYNDROME
The invention provides compositions for the prevention and treatment of the symptoms of alcoholic beverage-induced hangover syndrome, related kits and methods of using the compositions and kits. |
|
|
US20120053144 |
Cobalamin Taxane Bioconjugates For Treating Eye Disease
The present invention is directed to methods of treating eye disease. In one embodiment, the method can comprise administering a bioconjugate to a subject to treat the eye disease, where the... |
|
|
US20130210758 |
FORMULATION AND METHOD TO INDUCE A DEEP STATE OF RELAXATION
A relaxation formulation structured to induce a deep state of relaxation in a person comprises amounts of tryptophan, melatonin, vitamin B3, and vitamin B6. Another relaxation formulation also... |
|
|
US20120027723 |
TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION
The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the... |
|
|
US20140121646 |
Nutrient Absorption Barrier And Delivery Method
Methods and devices for preventing nutrient absorption in the small intestine wherein a medical device is passed through the esophagus, and positioned in the small intestine to treat the interior... |
|
|
US20120141611 |
METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS
In one embodiment, a composition containing ergothioneine and/or synthesized l-ergothioneine and one or more compounds selected from the group consisting of vitamin B-12, glucosamine sulfate,... |
|
|
US20150250752 |
COMPOSITION CONTAINING LYSINE AS A NUTRITIONAL SUPPLEMENT OR TREATMENT IN THE CASE OF HERPES
The invention relates to a composition comprising, related to a daily dose of the composition, as its active ingredients L-lysine ranging from ≧750 mg to −9 g, suitable as a nutritional supplement... |
|
|
US20090017136 |
Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders
The formulation provides for the treatment and prevention of fibromyalgia, depression and other muscle and nervous system disorders. The formulation combines Coenzyme Q10, vitamin B1,... |
|
|
US20110059171 |
ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES
The invention relates to a solid oral pharmaceutical composition combining ketorolac and B-complex consisting of inter alia thiamin, pyridoxine and cyanocobalamin (vitamins B1, B6 and B12... |
|
|
US20110020270 |
TREATMENT AND PROPHYLAXIS
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing... |
|
|
US20140242035 |
METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS
Methods for the treatment of a cell proliferation disorder in a subject, involving: (1) administering to the subject at least one activatable pharmaceutical agent that is capable of effecting a... |
|
|
US20130225521 |
PREVENTION OF MICRONUTRIENT DEFICIENCIES ASSOCIATED WITH COMMON DISABILITIES IN THE OVER 50 ADULT
A micronutrient dosage unit which comprises two or more micronutrients selected from vitamin A, vitamin B2, vitamin B6, vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K,... |
|
|
US20150005254 |
METHODS FOR TREATING OCULAR INFLAMMATORY DISORDERS
Provided are methods for treating ocular inflammatory disorders, including macular edema, using an AMP kinase activator, e.g., 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR). The... |
|
|
US20140161813 |
METHODS FOR THE DIAGNOSIS, TREATMENT AND MONITORING OF CANCER
New methods for diagnosing, treating, and monitoring cancer have been developed based on the expression level of markers, such as transcobalamin II (TCII), transcobalamin II receptor (TCIIR),... |
|
|
US20150030579 |
HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION
Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine,... |
|
|
US20120225840 |
HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION
Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine,... |
|
|
US20140315853 |
METHODS, FORMULATIONS, AND KITS FOR RAPIDLY REPLETING FOLATE LEVELS IN WOMEN
Disclosed are methods for rapidly repleting folate levels of a woman for whom there is reason to believe that she may be pregnant or of a woman who believes that she may soon become pregnant. One... |
|
|
US20150017260 |
COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREOF
A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a... |
|
|
US20110077194 |
Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method
A method and medical composition for the treatment and/or prevention of a functional Vitamin B12 deficiency in an individual that is brought about as a consequence of oxidative stress on... |
|
|
US20140148398 |
METHODS OF TREATING GIARDIASIS
Compounds useful for the treatment of giardiasis are described. |
|
|
US20120329749 |
Methods Of Preventing Or Treating Disease States Related To Certain Metabolic Abnormalities
The present invention relates to methods of treating, preventing, and/or improving disorders and conditions related to certain metabolic abnormalities including methods of improving blood lipid... |
|
|
US20110135753 |
Nutritional Supplement For Patients With Chronic Heart Failure
A nutritional supplement comprising the following approximate amounts: Vitamin/mineralRangeVitamin C60-150mgVitamin D (as cholecalciferol)400-10,000IUThiamin (Vitamin B1)1-50mgRiboflavin (Vitamin... |
|
|
US20110150854 |
RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES
It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the... |
|
|
US20120277179 |
Edible Energy Composition
The disclosure relates to an edible energy composition that provides physical and mental benefits when ingested. |
|
|
US20150182548 |
CYANOCOBALAMIN, METHYLCOBALAMIN, AND/OR ADENOSYLCOBALAMIN TO HELP MAINTAIN A PAIN-FREE HEAD AND PAIN-FREE BODY AND PROVIDE DEFENSE AGAINST HEADACHES AND BODY PAIN
The current invention discloses novel approaches to help individuals defend against headaches and body pains with orally-delivered cyanocobalamin, methylcobalamin, adenosylcobalamin, and... |
|
|
US20110135708 |
DIETARY SUPPLEMENT - LIQUID FILLED GUM
A new chewing gum comprising a gum member, with a central core or cavity, and a core element located within the central core or cavity. The chewing gum also comprises a dietary supplement, which... |
|
|
US20130059813 |
TREATMENT OF DERMATOLOGICAL CONDITIONS
The present disclosure provides a method for treating dermatological conditions, such as psoriasis, dermatitis, and dandruff. Said conditions are treated by administering to a person a vitamin... |
|
|
US20130095190 |
ORAL LIQUID VITAMIN AND SUPPLEMENT COMPOSITIONS
Disclosed are health drink compositions. One example composition provides a health drink that includes 10-15 mg/10 ml of calcium lactate gluconate, 400-600 mcg/10 ml of folic acid, 40-50 mg/10 ml... |
|
|
US20110275591 |
COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE
Formulations for the prevention and treatment of neurological diseases and cognitive deficiencies, i.e., Alzheimer's Disease (AD), Parkinson's Disease, amyotrophic lateral sclerosis, mild... |
|
|
US20110166097 |
TAXANE COMPOUNDS FOR TREATING EYE DISEASE
The present invention is directed to methods of treating eye disease. In one embodiment, the method can comprise administering a taxane-cobalamin bioconjugate or another taxane compound to a... |
|
|
US20110123510 |
Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis
The present invention relates to methods of regulating biological functions in a mammal that are mediated, at least in part, by the circadian clock. |
|
|
US20130171151 |
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
Aspects of the invention provide methods for treatment of nonalcoholic steatohepatitis and associated liver fibrosis. In particular, aspects of the invention relate to the use of a therapeutic... |
|
|
US20090136592 |
Vitamin preparation
Two-phase preparation for temporally gradual administration comprising a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not contain... |